14 results
6-K
EX-2.1
GRCL
Gracell Biotechnologies Inc
26 Dec 23
Voting and Support Agreement
8:12am
extension, manufacturing and supply chain, product profile, safety and efficacy, actual and anticipated product labeling, the competitiveness
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
18 Aug 21
Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corporate Update
7:42am
of Dr. Jenny (Yajin) Ni, as Chief Technology Officer. Dr. Ni will strategically lead CAR-T process development, CMC and supply chain management
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
20 May 21
Gracell Biotechnologies Reports First Quarter 2021 Unaudited
7:07am
Technology Officer. Dr. Ni will strategically lead CAR-T process development, CMC and supply chain management activities at Gracell (Press Release May
6-K
EX-99.1
to9zdx dhiktucz
11 May 21
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer
4:05pm
20-F
8r9 2g8svv
23 Apr 21
Annual report (foreign)
4:04pm
424B4
hakc97l9 0nwh63b
8 Jan 21
Prospectus supplement with pricing info
1:42pm
F-1/A
osahh77enkbha96hj1c1
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
zgv9ee4s9mj
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
ap05 tetzg
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
1cij645
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
303gdoyeb vku
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
oizth8py3wg73m2371ch
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next